FERMT2 and cancer: Immunohistochemistry on tumours from mouse models validated this finding, showing significant downregulation of pFAK(397) (Fig. 7c&d), a key signaling mediator of integrin activation and cancer cell survival, upon Tns1 and Fermt2 inhibition.